# Purple Biotech Ltd. (PPBT)

Source page: https://stoqly.net/companies/ppbt

- **Ticker:** PPBT (Nasdaq)
- **Sector:** Health Care / Pharmaceutical Preparations
- **SEC CIK:** 0001614744
- **Latest annual report:** 20-F filed 2026-03-19 (https://www.sec.gov/Archives/edgar/data/1614744/000121390026031365/ea0281765-20f_purple.htm)
- **Data updated:** 2026-11-01

## Key figures

- **Last close:** $1.17 on 2026-10-30
- **Free cash flow:** −$5.7M
- **Return on equity:** −124.0%
- **Change in share count:** −70.7%
- **Insider buys, last 90 days:** $0.0M
- **Insider sells, last 90 days:** $0.0M

Definitions: https://stoqly.net/about

## Annual results

From SEC EDGAR XBRL filings. Full table: https://stoqly.net/companies/ppbt/figures.csv

| US$ millions | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|
| Revenue | — | 0 | 1 | 1 | 1 | — | — | — | — | — |
| Operating income | -7 | -12 | -8 | -7 | -13 | -18 | -23 | -22 | — | — |
| Net income | 12 | 12 | 5 | 6 | 28 | 18 | -22 | -20 | -7 | -26 |
| Diluted EPS (US$) | 2.11 | 1.37 | -3.90 | -3.00 | 2.44 | 17,568,036.00 | 23.97 | 17.96 | 4.99 | 0.03 |
| Operating cash flow | -6 | -9 | -8 | -2 | 2 | 0 | -17 | -20 | -14 | -6 |
| Free cash flow | -6 | -9 | -8 | -2 | 2 | 0 | -17 | -20 | — | -6 |
| Cash | 7 | 4 | 5 | 4 | 11 | 11 | 15 | 14 | 7 | 9 |

---

Source: SEC EDGAR filings and end-of-day prices, via Stoqly. For information only — not investment advice or a recommendation to buy, sell or hold any security.